Should patients with severe heart failure be treated with beta blockers?

Article Type
Changed
Wed, 01/16/2019 - 08:36
Display Headline
Should patients with severe heart failure be treated with beta blockers?
Article PDF
Author and Disclosure Information

Robert E. Hobbs, MD, FACC
Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, Cleveland Clinic

Address: Robert F. Hobbs, MD, FACC, Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hobbsr@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 68(5)
Publications
Topics
Page Number
469-470
Sections
Author and Disclosure Information

Robert E. Hobbs, MD, FACC
Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, Cleveland Clinic

Address: Robert F. Hobbs, MD, FACC, Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hobbsr@ccf.org

Author and Disclosure Information

Robert E. Hobbs, MD, FACC
Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, Cleveland Clinic

Address: Robert F. Hobbs, MD, FACC, Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hobbsr@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Page Number
469-470
Page Number
469-470
Publications
Publications
Topics
Article Type
Display Headline
Should patients with severe heart failure be treated with beta blockers?
Display Headline
Should patients with severe heart failure be treated with beta blockers?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

High or low doses of ACE inhibitors for heart failure?

Article Type
Changed
Fri, 04/05/2019 - 11:34
Display Headline
High or low doses of ACE inhibitors for heart failure?
Results of the ATLAS study
Article PDF
Author and Disclosure Information

Robert E. Hobbs, MD
Section of Heart Failure/Transplant, Department of Cardiology, Cleveland Clinic

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 65(10)
Publications
Page Number
539-542
Sections
Author and Disclosure Information

Robert E. Hobbs, MD
Section of Heart Failure/Transplant, Department of Cardiology, Cleveland Clinic

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Robert E. Hobbs, MD
Section of Heart Failure/Transplant, Department of Cardiology, Cleveland Clinic

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Results of the ATLAS study
Results of the ATLAS study
Issue
Cleveland Clinic Journal of Medicine - 65(10)
Issue
Cleveland Clinic Journal of Medicine - 65(10)
Page Number
539-542
Page Number
539-542
Publications
Publications
Article Type
Display Headline
High or low doses of ACE inhibitors for heart failure?
Display Headline
High or low doses of ACE inhibitors for heart failure?
Sections
Citation Override
Cleveland Clinic Journal of Medicine 1998 November/December;65(10):539-542
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study

Article Type
Changed
Fri, 04/26/2019 - 10:08
Display Headline
Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study
Article PDF
Author and Disclosure Information

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 64(5)
Publications
Page Number
234-327
Sections
Author and Disclosure Information

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(5)
Issue
Cleveland Clinic Journal of Medicine - 64(5)
Page Number
234-327
Page Number
234-327
Publications
Publications
Article Type
Display Headline
Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study
Display Headline
Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media